• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1120350-23
Device Problems Inflation Problem (1310); Leak/Splash (1354); Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/24/2022
Event Type  Injury  
Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a 95% stenosed lesion.A 3.5x23mm xience alpine drug eluting stent (des) was advanced to the target lesion; however, the balloon only partially inflated.Several attempts were made to inflate the balloon, but only the distal 2/3 of the stent expanded.The stent dislodged from the balloon at the target lesion and was able to be snared and removed from the anatomy.There was no adverse patient sequela or a clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulties; however, the subsequent treatment appears to be related to the operational context of the procedure.Additionally, the reported removal of a foreign body was due to a dislodged stent within the anatomy.Factors that may contribute to a dislodged stent include, but are not limited to, improper or inadequate crimping at the time of manufacture, handling of the stent during preparation, interaction with challenging anatomy, and/or interaction with accessory devices.Factors that may contribute to a leak include, but are not limited to, damage to the inflation lumen, loose connection with the indeflator, and/or damage to the balloon.Factors that may contribute to an inflation problem include, but are not limited to, anatomical morphology, loose connection with the indeflator, contamination in the inflation lumen, and/or damage to the inflation lumen.In this case, it is possible that the stent delivery system (sds) interacted with the 95% stenosed anatomy and/or accessory devices during advancement, resulting in the reported leak and subsequently contributed to the reported inflation problem.Additionally, it is possible the failed inflation and/or interaction with the challenging anatomy contributed to the reported stent dislodgement; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event Description
Subsequent to the initial filed report, the following information was received: it was reported that the procedure was to treat an unknown, 95% stenosed lesion.A 3.5x23mm xience alpine drug eluting stent (des) was advanced to the target lesion, however the balloon only partially inflated, and stent detached from the balloon at the target lesion.The stent was snared from the anatomy.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14782086
MDR Text Key294954640
Report Number2024168-2022-06734
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAR
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1120350-23
Device Lot Number1090241
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient SexMale
Patient Weight75 KG
-
-